FdaApplication
NDA 013217
Identifiers
- fda_app_no: NDA013217
Properties
| Property | Value |
|---|---|
| applicant_name | KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT LLC A SUB OF PFIZER INC |
| application_type | NDA |
| approval_date | 2002-08-30 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SKELAXIN | METAXALONE | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| SKELAXIN | METAXALONE | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products